IBM And EU Partners Create A Better Way To Fight AIDS Virus

IBM (NYSE: IBM) today announced it was selected for its contributions to the EuResist research project for AIDS treatment as a Computerworld Honors Program Laureate for 2009. Developed by IBM researchers in Haifa, Israel, the project’s new technologies and mathematical models are providing a smarter and more efficient way to choose the best drugs combinations for any given HIV genetic variant.

More: continued here

Filed under: HIV / AIDS on June 5th, 2009